nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—STAT3—ovarian cancer	0.805	1	CbGaD
Niclosamide—STAT3—myometrium—ovarian cancer	0.0053	0.106	CbGeAlD
Niclosamide—STAT3—embryo—ovarian cancer	0.0051	0.102	CbGeAlD
Niclosamide—STAT3—epithelium—ovarian cancer	0.00416	0.0834	CbGeAlD
Niclosamide—STAT3—uterine cervix—ovarian cancer	0.00412	0.0827	CbGeAlD
Niclosamide—STAT3—decidua—ovarian cancer	0.00393	0.0788	CbGeAlD
Niclosamide—STAT3—endometrium—ovarian cancer	0.00373	0.0748	CbGeAlD
Niclosamide—STAT3—gonad—ovarian cancer	0.00346	0.0694	CbGeAlD
Niclosamide—STAT3—uterus—ovarian cancer	0.00344	0.069	CbGeAlD
Niclosamide—STAT3—female reproductive system—ovarian cancer	0.00309	0.062	CbGeAlD
Niclosamide—STAT3—bone marrow—ovarian cancer	0.00292	0.0585	CbGeAlD
Niclosamide—STAT3—female gonad—ovarian cancer	0.00281	0.0564	CbGeAlD
Niclosamide—STAT3—vagina—ovarian cancer	0.0028	0.0561	CbGeAlD
Niclosamide—STAT3—testis—ovarian cancer	0.00249	0.05	CbGeAlD
Niclosamide—STAT3—lymph node—ovarian cancer	0.00181	0.0363	CbGeAlD
Niclosamide—CYP2C9—female reproductive system—ovarian cancer	0.000694	0.0139	CbGeAlD
Niclosamide—STAT3—Signaling by FGFR in disease—EGFR—ovarian cancer	8.33e-05	0.000572	CbGpPWpGaD
Niclosamide—STAT3—Disease—HDAC6—ovarian cancer	8.29e-05	0.000569	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CXCL8—ovarian cancer	8.28e-05	0.000568	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—PIK3CB—ovarian cancer	8.22e-05	0.000564	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—IL6—ovarian cancer	8.2e-05	0.000563	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—ERBB2—ovarian cancer	8.19e-05	0.000562	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—MAPK1—ovarian cancer	8.15e-05	0.00056	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—DOK1—ovarian cancer	8.15e-05	0.00056	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—EGFR—ovarian cancer	8.15e-05	0.00056	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—NRAS—ovarian cancer	8.1e-05	0.000556	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CDKN1B—ovarian cancer	8.09e-05	0.000555	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—MTOR—ovarian cancer	8.08e-05	0.000555	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—PIK3CB—ovarian cancer	8.08e-05	0.000555	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—HRAS—ovarian cancer	8.03e-05	0.000551	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—MAPK1—ovarian cancer	8.01e-05	0.00055	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—HRAS—ovarian cancer	7.89e-05	0.000542	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—KRAS—ovarian cancer	7.87e-05	0.00054	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—PIK3CA—ovarian cancer	7.8e-05	0.000536	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—MAPK3—ovarian cancer	7.76e-05	0.000533	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—KRAS—ovarian cancer	7.7e-05	0.000529	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—IL6—ovarian cancer	7.68e-05	0.000527	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PPP1CC—ovarian cancer	7.66e-05	0.000526	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—CDKN1B—ovarian cancer	7.58e-05	0.000521	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL2—ovarian cancer	7.55e-05	0.000518	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—CASP3—ovarian cancer	7.43e-05	0.00051	CbGpPWpGaD
Niclosamide—STAT3—Immune System—EREG—ovarian cancer	7.41e-05	0.000509	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IKBKG—ovarian cancer	7.41e-05	0.000509	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—MAPK1—ovarian cancer	7.38e-05	0.000507	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—EGFR—ovarian cancer	7.38e-05	0.000507	CbGpPWpGaD
Niclosamide—STAT3—Immune System—SKP2—ovarian cancer	7.24e-05	0.000497	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MET—ovarian cancer	7.24e-05	0.000497	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—PIK3CA—ovarian cancer	7.23e-05	0.000497	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—HRAS—ovarian cancer	7.22e-05	0.000496	CbGpPWpGaD
Niclosamide—STAT3—Disease—XIAP—ovarian cancer	7.19e-05	0.000494	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—HRAS—ovarian cancer	7.18e-05	0.000493	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—IL6ST—ovarian cancer	7.09e-05	0.000487	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—AKT1—ovarian cancer	7.09e-05	0.000487	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—PIK3CA—ovarian cancer	7.07e-05	0.000486	CbGpPWpGaD
Niclosamide—STAT3—Disease—SMARCA4—ovarian cancer	7.01e-05	0.000481	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—PTEN—ovarian cancer	6.98e-05	0.000479	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—KRAS—ovarian cancer	6.97e-05	0.000479	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—AKT1—ovarian cancer	6.97e-05	0.000478	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—IL6—ovarian cancer	6.91e-05	0.000474	CbGpPWpGaD
Niclosamide—STAT3—Disease—EREG—ovarian cancer	6.84e-05	0.00047	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—VEGFA—ovarian cancer	6.72e-05	0.000462	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—TP53—ovarian cancer	6.72e-05	0.000462	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—HRAS—ovarian cancer	6.69e-05	0.000459	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—HRAS—ovarian cancer	6.54e-05	0.000449	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—PIK3CA—ovarian cancer	6.4e-05	0.00044	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—IL6—ovarian cancer	6.4e-05	0.00044	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—AKT1—ovarian cancer	6.37e-05	0.000438	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—MAPK3—ovarian cancer	6.36e-05	0.000437	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—AKT1—ovarian cancer	6.34e-05	0.000435	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—NRAS—ovarian cancer	6.34e-05	0.000435	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—IL6—ovarian cancer	6.26e-05	0.00043	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—NRAS—ovarian cancer	6.23e-05	0.000428	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—IL6—ovarian cancer	6.15e-05	0.000423	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—MAPK3—ovarian cancer	6.07e-05	0.000417	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—MAPK1—ovarian cancer	6.05e-05	0.000416	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MMP2—ovarian cancer	6.04e-05	0.000414	CbGpPWpGaD
Niclosamide—STAT3—Disease—FASN—ovarian cancer	5.98e-05	0.000411	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—MAPK3—ovarian cancer	5.97e-05	0.00041	CbGpPWpGaD
Niclosamide—STAT3—Disease—PARP1—ovarian cancer	5.96e-05	0.000409	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—HRAS—ovarian cancer	5.93e-05	0.000407	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—AKT1—ovarian cancer	5.91e-05	0.000406	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HDAC6—ovarian cancer	5.81e-05	0.000399	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—AKT1—ovarian cancer	5.78e-05	0.000397	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—MAPK1—ovarian cancer	5.77e-05	0.000396	CbGpPWpGaD
Niclosamide—STAT3—Disease—SLC2A1—ovarian cancer	5.68e-05	0.00039	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	5.68e-05	0.00039	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	5.68e-05	0.00039	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—MAPK1—ovarian cancer	5.68e-05	0.00039	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—EGFR—ovarian cancer	5.68e-05	0.00039	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—IL6—ovarian cancer	5.67e-05	0.000389	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	5.56e-05	0.000382	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—KRAS—ovarian cancer	5.45e-05	0.000374	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	5.42e-05	0.000372	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—KRAS—ovarian cancer	5.36e-05	0.000368	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	5.35e-05	0.000367	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—ERBB2—ovarian cancer	5.29e-05	0.000363	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PPP2R1A—ovarian cancer	5.23e-05	0.000359	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—AKT1—ovarian cancer	5.23e-05	0.000359	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—YAP1—ovarian cancer	5.14e-05	0.000353	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—TP53—ovarian cancer	5.08e-05	0.000349	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—XIAP—ovarian cancer	5.04e-05	0.000346	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—PIK3CA—ovarian cancer	5.01e-05	0.000344	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—PIK3CA—ovarian cancer	4.93e-05	0.000338	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SMARCA4—ovarian cancer	4.91e-05	0.000337	CbGpPWpGaD
Niclosamide—STAT3—Disease—PPP2R1A—ovarian cancer	4.83e-05	0.000332	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—EREG—ovarian cancer	4.79e-05	0.000329	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	4.72e-05	0.000324	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	4.67e-05	0.00032	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD8A—ovarian cancer	4.67e-05	0.00032	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—IL6—ovarian cancer	4.65e-05	0.000319	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HRAS—ovarian cancer	4.64e-05	0.000318	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	4.63e-05	0.000318	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—CTNNB1—ovarian cancer	4.63e-05	0.000318	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	4.57e-05	0.000314	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—HRAS—ovarian cancer	4.56e-05	0.000313	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MMP9—ovarian cancer	4.54e-05	0.000311	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PGR—ovarian cancer	4.49e-05	0.000308	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL6—ovarian cancer	4.44e-05	0.000305	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—IL6—ovarian cancer	4.36e-05	0.0003	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	4.35e-05	0.000298	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	4.25e-05	0.000292	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	4.25e-05	0.000292	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	4.25e-05	0.000292	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	4.18e-05	0.000287	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PARP1—ovarian cancer	4.17e-05	0.000286	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—VEGFA—ovarian cancer	4.07e-05	0.00028	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—AKT1—ovarian cancer	4.02e-05	0.000276	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—NRAS—ovarian cancer	4.02e-05	0.000276	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	4.02e-05	0.000276	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MAPK3—ovarian cancer	3.85e-05	0.000265	CbGpPWpGaD
Niclosamide—STAT3—Disease—TERT—ovarian cancer	3.84e-05	0.000264	CbGpPWpGaD
Niclosamide—STAT3—Immune System—TLR4—ovarian cancer	3.8e-05	0.000261	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MAPK1—ovarian cancer	3.67e-05	0.000252	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—EGFR—ovarian cancer	3.67e-05	0.000252	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL6ST—ovarian cancer	3.65e-05	0.00025	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	3.57e-05	0.000245	CbGpPWpGaD
Niclosamide—STAT3—Disease—CAV1—ovarian cancer	3.55e-05	0.000244	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—KRAS—ovarian cancer	3.46e-05	0.000238	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	3.41e-05	0.000234	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PPP2R1A—ovarian cancer	3.38e-05	0.000232	CbGpPWpGaD
Niclosamide—STAT3—Disease—IL6ST—ovarian cancer	3.37e-05	0.000231	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NME2—ovarian cancer	3.31e-05	0.000227	CbGpPWpGaD
Niclosamide—STAT3—Disease—APC—ovarian cancer	3.23e-05	0.000222	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CDH1—ovarian cancer	3.22e-05	0.000221	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PIK3CD—ovarian cancer	3.08e-05	0.000211	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—HRAS—ovarian cancer	2.94e-05	0.000202	CbGpPWpGaD
Niclosamide—STAT3—Disease—PIK3CD—ovarian cancer	2.84e-05	0.000195	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NME2—ovarian cancer	2.82e-05	0.000194	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—IL6—ovarian cancer	2.82e-05	0.000193	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.8e-05	0.000193	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ERBB2—ovarian cancer	2.72e-05	0.000187	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TERT—ovarian cancer	2.69e-05	0.000185	CbGpPWpGaD
Niclosamide—STAT3—Immune System—MTOR—ovarian cancer	2.68e-05	0.000184	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PIK3CB—ovarian cancer	2.68e-05	0.000184	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—AKT1—ovarian cancer	2.6e-05	0.000178	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CDKN1B—ovarian cancer	2.52e-05	0.000173	CbGpPWpGaD
Niclosamide—STAT3—Disease—ERBB2—ovarian cancer	2.51e-05	0.000172	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CAV1—ovarian cancer	2.49e-05	0.000171	CbGpPWpGaD
Niclosamide—STAT3—Disease—PIK3CB—ovarian cancer	2.48e-05	0.00017	CbGpPWpGaD
Niclosamide—STAT3—Disease—MTOR—ovarian cancer	2.48e-05	0.00017	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL2—ovarian cancer	2.47e-05	0.000169	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ESR1—ovarian cancer	2.4e-05	0.000165	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.4e-05	0.000165	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CTNNB1—ovarian cancer	2.38e-05	0.000163	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL6ST—ovarian cancer	2.36e-05	0.000162	CbGpPWpGaD
Niclosamide—STAT3—Disease—CDKN1B—ovarian cancer	2.33e-05	0.00016	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PTEN—ovarian cancer	2.32e-05	0.000159	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.29e-05	0.000157	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—APC—ovarian cancer	2.27e-05	0.000156	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3CG—ovarian cancer	2.27e-05	0.000156	CbGpPWpGaD
Niclosamide—STAT3—Disease—CTNNB1—ovarian cancer	2.2e-05	0.000151	CbGpPWpGaD
Niclosamide—STAT3—Disease—PTEN—ovarian cancer	2.14e-05	0.000147	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYTB—ovarian cancer	2.13e-05	0.000146	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.08e-05	0.000143	CbGpPWpGaD
Niclosamide—STAT3—Immune System—NRAS—ovarian cancer	2.07e-05	0.000142	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3CD—ovarian cancer	1.99e-05	0.000137	CbGpPWpGaD
Niclosamide—STAT3—Immune System—MAPK3—ovarian cancer	1.98e-05	0.000136	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.95e-05	0.000134	CbGpPWpGaD
Niclosamide—STAT3—Disease—NRAS—ovarian cancer	1.91e-05	0.000131	CbGpPWpGaD
Niclosamide—STAT3—Immune System—MAPK1—ovarian cancer	1.89e-05	0.000129	CbGpPWpGaD
Niclosamide—STAT3—Immune System—EGFR—ovarian cancer	1.89e-05	0.000129	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.86e-05	0.000128	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.86e-05	0.000128	CbGpPWpGaD
Niclosamide—STAT3—Disease—MAPK3—ovarian cancer	1.83e-05	0.000126	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYTB—ovarian cancer	1.82e-05	0.000125	CbGpPWpGaD
Niclosamide—STAT3—Immune System—KRAS—ovarian cancer	1.78e-05	0.000122	CbGpPWpGaD
Niclosamide—STAT3—Disease—MYC—ovarian cancer	1.78e-05	0.000122	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.78e-05	0.000122	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ERBB2—ovarian cancer	1.76e-05	0.000121	CbGpPWpGaD
Niclosamide—STAT3—Disease—MAPK1—ovarian cancer	1.74e-05	0.00012	CbGpPWpGaD
Niclosamide—STAT3—Disease—EGFR—ovarian cancer	1.74e-05	0.00012	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MTOR—ovarian cancer	1.74e-05	0.000119	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3CB—ovarian cancer	1.74e-05	0.000119	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CXCL8—ovarian cancer	1.67e-05	0.000115	CbGpPWpGaD
Niclosamide—STAT3—Disease—KRAS—ovarian cancer	1.64e-05	0.000113	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PIK3CA—ovarian cancer	1.64e-05	0.000112	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CDKN1B—ovarian cancer	1.63e-05	0.000112	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CASP3—ovarian cancer	1.6e-05	0.00011	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL2—ovarian cancer	1.59e-05	0.000109	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.59e-05	0.000109	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.59e-05	0.000109	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCND1—ovarian cancer	1.55e-05	0.000107	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CTNNB1—ovarian cancer	1.54e-05	0.000106	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HRAS—ovarian cancer	1.51e-05	0.000104	CbGpPWpGaD
Niclosamide—STAT3—Disease—PIK3CA—ovarian cancer	1.51e-05	0.000104	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MMP9—ovarian cancer	1.51e-05	0.000104	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PTEN—ovarian cancer	1.5e-05	0.000103	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL6—ovarian cancer	1.45e-05	9.95e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—HRAS—ovarian cancer	1.4e-05	9.6e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.36e-05	9.32e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—VEGFA—ovarian cancer	1.35e-05	9.3e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NRAS—ovarian cancer	1.34e-05	9.19e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—IL6—ovarian cancer	1.34e-05	9.19e-05	CbGpPWpGaD
Niclosamide—STAT3—Immune System—AKT1—ovarian cancer	1.34e-05	9.18e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MAPK3—ovarian cancer	1.28e-05	8.8e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—YAP1—ovarian cancer	1.25e-05	8.57e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MYC—ovarian cancer	1.25e-05	8.56e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.24e-05	8.49e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—AKT1—ovarian cancer	1.23e-05	8.48e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MAPK1—ovarian cancer	1.22e-05	8.37e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—EGFR—ovarian cancer	1.22e-05	8.37e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.16e-05	7.96e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—KRAS—ovarian cancer	1.15e-05	7.91e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.09e-05	7.46e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—YAP1—ovarian cancer	1.07e-05	7.33e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3CA—ovarian cancer	1.06e-05	7.27e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.06e-05	7.25e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TP53—ovarian cancer	1.02e-05	7.03e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—FASN—ovarian cancer	1.02e-05	6.99e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1e-05	6.88e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HRAS—ovarian cancer	9.79e-06	6.72e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SLC2A1—ovarian cancer	9.67e-06	6.64e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.47e-06	6.5e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL6—ovarian cancer	9.37e-06	6.43e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.28e-06	6.37e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP1B1—ovarian cancer	9.27e-06	6.37e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—FASN—ovarian cancer	8.7e-06	5.97e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AKT1—ovarian cancer	8.64e-06	5.94e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SLC5A5—ovarian cancer	8.56e-06	5.88e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SLC2A1—ovarian cancer	8.26e-06	5.67e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	8.22e-06	5.65e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.18e-06	5.62e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.09e-06	5.56e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP1B1—ovarian cancer	7.92e-06	5.44e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ABCB1—ovarian cancer	7.64e-06	5.24e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—TYMS—ovarian cancer	7.5e-06	5.15e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	7.03e-06	4.83e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.99e-06	4.8e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ABCB1—ovarian cancer	6.52e-06	4.48e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—TYMS—ovarian cancer	6.41e-06	4.4e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CAV1—ovarian cancer	6.04e-06	4.15e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.77e-06	3.96e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3CG—ovarian cancer	5.5e-06	3.78e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CAV1—ovarian cancer	5.16e-06	3.55e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.93e-06	3.39e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3CD—ovarian cancer	4.84e-06	3.32e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3CG—ovarian cancer	4.7e-06	3.23e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3CB—ovarian cancer	4.22e-06	2.9e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3CD—ovarian cancer	4.13e-06	2.84e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PTEN—ovarian cancer	3.64e-06	2.5e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3CB—ovarian cancer	3.6e-06	2.47e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PTEN—ovarian cancer	3.11e-06	2.14e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.57e-06	1.77e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3CA—ovarian cancer	2.2e-06	1.51e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AKT1—ovarian cancer	2.1e-06	1.44e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AKT1—ovarian cancer	1.79e-06	1.23e-05	CbGpPWpGaD
